<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="11461">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00572533</url>
  </required_header>
  <id_info>
    <org_study_id>K25DK072085</org_study_id>
    <secondary_id>K25DK072085</secondary_id>
    <secondary_id>1K25DK072085-01A2</secondary_id>
    <nct_id>NCT00572533</nct_id>
  </id_info>
  <brief_title>Intelligent Control Approach to Anemia Management</brief_title>
  <official_title>Intelligent Control Approach to Anemia Management (AIM 4)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      First clinical evaluation of &quot;Smart Anemia Manager&quot; algorithm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this single-center study is to test whether &quot;Smart Anemia Manager&quot; algorithm
      improves Hemoglobin stability compared to standard Anemia Management Protocol. Study site:
      Kidney Disease Program dialysis facility, University of Louisville, Louisville, KY.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver)</study_design>
  <primary_outcome>
    <measure>Percent Hb 10-12 g/dL</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percentage of Hemoglobin concentrations measured (once per month) between 10 and 12 g/dL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Hb &lt; 10 g/dL</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percentage of Hemoglobin concentrations measured (once per month) less than 10 g/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Hb &gt; 12 g/dL</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Percentage of Hemoglobin concentrations measured (once per month) greater than 12 g/dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Hb</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean Hemoglobin concentration over follow-up period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ESA Dose</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Mean ESA dose per patient-week. ESA used: Epoetin Alfa (IV)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">62</enrollment>
  <condition>End-Stage Renal Disease</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ESA Dose Adjustment per standard Anemia Management Protocol</intervention_name>
    <description>Amount of ESA dose adjustment in Units per week guided by standard Anemia Management Protocol in use at the facility</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>AMP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</intervention_name>
    <description>Amount of ESA dose adjustment in Units per week individualized to subject's dose-response profile guided by &quot;Smart Anemia Manager&quot; algorithm</description>
    <arm_group_label>Treatment</arm_group_label>
    <other_name>SAM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          1. ages 18 to 80,

          2. receiving dialysis treatment,

          3. receiving or expected to receive ESA treatment,

          4. adequacy of dialysis Kt/V &gt;= 1.2,

          5. adequate iron stores (Ferritin &gt; 200 ng/mL, TSat &gt; 20%).

        Exclusion criteria:

          1. life expectancy less than 12 months,

          2. frequent uncontrolled blood loss,

          3. frequent dialyzer clotting,

          4. frequent access related problems,

          5. active infections,

          6. severe cardiac disability,

          7. coronary bypass within three months prior to the study

          8. documented resistance to ESA

          9. bone marrow suppression due to HIV, leukemia, or pharmacologic agents.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam E Gaweda, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Louisville Kidney Disease Program</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>December 19, 2012</lastchanged_date>
  <firstreceived_date>December 11, 2007</firstreceived_date>
  <firstreceived_results_date>October 15, 2012</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>End-Stage Renal Disease</keyword>
  <keyword>Chronic Hemodialysis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>No</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control</title>
          <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
        </group>
        <group group_id="P2">
          <title>Treatment</title>
          <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Received Kidney Transplant</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Social Issues</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Transfer out of Facility</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control</title>
          <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
        </group>
        <group group_id="B2">
          <title>Treatment</title>
          <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="31"/>
                <measurement group_id="B3" value="62"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="24"/>
                <measurement group_id="B2" value="27"/>
                <measurement group_id="B3" value="51"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="7"/>
                <measurement group_id="B2" value="4"/>
                <measurement group_id="B3" value="11"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="57" spread="10"/>
                <measurement group_id="B2" value="57" spread="9"/>
                <measurement group_id="B3" value="57" spread="9"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
                <measurement group_id="B2" value="11"/>
                <measurement group_id="B3" value="20"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="22"/>
                <measurement group_id="B2" value="20"/>
                <measurement group_id="B3" value="42"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>American Indian or Alaska Native</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Asian</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Native Hawaiian or Other Pacific Islander</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black or African American</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="21"/>
                <measurement group_id="B3" value="41"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="11"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="21"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>More than one race</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Unknown or Not Reported</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="31"/>
                <measurement group_id="B2" value="31"/>
                <measurement group_id="B3" value="62"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Diabetes</title>
          <description>Number of subjects with diagnosed diabetes</description>
          <units>Participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Diabetes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="17"/>
                <measurement group_id="B2" value="18"/>
                <measurement group_id="B3" value="35"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No Diabetes</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="14"/>
                <measurement group_id="B2" value="13"/>
                <measurement group_id="B3" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Congestive Heart Failure (CHF)</title>
          <description>Number of subjects with diagnosed CHF</description>
          <units>Subjects</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>CHF</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="14"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>No CHF</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="25"/>
                <measurement group_id="B2" value="23"/>
                <measurement group_id="B3" value="48"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Vascular Access Type</title>
          <description>Number of patients with specific vascular access type</description>
          <units>Participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Fistula</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="20"/>
                <measurement group_id="B2" value="21"/>
                <measurement group_id="B3" value="41"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Catheter</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="3"/>
                <measurement group_id="B3" value="9"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Graft</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="5"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="12"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Hemoglobin (g/dL)</title>
          <description>Hemoglobin concentration in March 2011</description>
          <units>g/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="11.2" spread="1.4"/>
                <measurement group_id="B2" value="11.3" spread="1.0"/>
                <measurement group_id="B3" value="11.3" spread="1.2"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>ESA dose</title>
          <description>ESA dose across group in March 2011</description>
          <units>IU/week/subject</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="4,645" spread="7,468"/>
                <measurement group_id="B2" value="5,290" spread="7,751"/>
                <measurement group_id="B3" value="4,968" spread="7,555"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent Hb 10-12 g/dL</title>
        <description>Percentage of Hemoglobin concentrations measured (once per month) between 10 and 12 g/dL.</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat Analysis, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent Hb 10-12 g/dL</title>
            <description>Percentage of Hemoglobin concentrations measured (once per month) between 10 and 12 g/dL.</description>
            <units>Percent</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="61.9"/>
                  <measurement group_id="O2" value="72.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Hb &lt; 10 g/dL</title>
        <description>Percentage of Hemoglobin concentrations measured (once per month) less than 10 g/dL.</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat Analysis, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent Hb &lt; 10 g/dL</title>
            <description>Percentage of Hemoglobin concentrations measured (once per month) less than 10 g/dL.</description>
            <units>Percent</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="24.7"/>
                  <measurement group_id="O2" value="11.8"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Transfusion Events</title>
        <description>Number of Transfusion Events</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Transfusion Events</title>
            <description>Number of Transfusion Events</description>
            <units>Events</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="13"/>
                  <measurement group_id="O2" value="6"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Hb &gt; 12 g/dL</title>
        <description>Percentage of Hemoglobin concentrations measured (once per month) greater than 12 g/dL.</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat, Missed Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Percent Hb &gt; 12 g/dL</title>
            <description>Percentage of Hemoglobin concentrations measured (once per month) greater than 12 g/dL.</description>
            <units>Percent</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="13.4"/>
                  <measurement group_id="O2" value="15.7"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Hb</title>
        <description>Mean Hemoglobin concentration over follow-up period</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat Analysis, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Hb</title>
            <description>Mean Hemoglobin concentration over follow-up period</description>
            <units>g/dL</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="10.7" spread="1.5"/>
                  <measurement group_id="O2" value="11.0" spread="1.2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ESA Dose</title>
        <description>Mean ESA dose per patient-week. ESA used: Epoetin Alfa (IV)</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-to-Treat Analysis, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>ESA Dose</title>
            <description>Mean ESA dose per patient-week. ESA used: Epoetin Alfa (IV)</description>
            <units>IU</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3,033" spread="3,592"/>
                  <measurement group_id="O2" value="3,704" spread="5,221"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>Subjects Receiving Transfusion</title>
        <description>Number of Subjects receiving Transfusion</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Subjects Receiving Transfusion</title>
            <description>Number of Subjects receiving Transfusion</description>
            <units>Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Post-Hoc</type>
        <title>RBC Units Transfused</title>
        <description>Total number of RBC units transfused</description>
        <time_frame>12 months</time_frame>
        <safety_issue>No</safety_issue>
        <population>Intent-To-Treat, Missing Data Excluded</population>
        <group_list>
          <group group_id="O1">
            <title>Control</title>
            <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
          </group>
          <group group_id="O2">
            <title>Treatment</title>
            <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="31"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>RBC Units Transfused</title>
            <description>Total number of RBC units transfused</description>
            <units>RBC Units</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="31"/>
                  <measurement group_id="O2" value="21"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>04/01/2011 - 03/31/2012</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control</title>
          <description>ESA Dose Adjustment per standard Anemia Management Protocol</description>
        </group>
        <group group_id="E2">
          <title>Treatment</title>
          <description>ESA Dose Adjustment per &quot;Smart Anemia Manager&quot; Algorithm</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Composite Safety Event (ACM, MI, CVA, CHF)</sub_title>
                <description>All-Cause Mortality, Myocardial Infarction, Cerebrovascular Accident, Congestive Heart Failure</description>
                <counts group_id="E1" events="10" subjects_affected="6" subjects_at_risk="31"/>
                <counts group_id="E2" events="11" subjects_affected="10" subjects_at_risk="31"/>
              </event>
              <event>
                <sub_title>Hospitalization</sub_title>
                <description>All-Cause Hospitalization (includes hospitalization due to Composite Safety Event)</description>
                <counts group_id="E1" events="39" subjects_affected="18" subjects_at_risk="31"/>
                <counts group_id="E2" events="41" subjects_affected="18" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="31"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="31"/>
                <counts group_id="E2" events="10" subjects_affected="6" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Vascular Access Event</sub_title>
                <counts group_id="E1" events="27" subjects_affected="17" subjects_at_risk="31"/>
                <counts group_id="E2" events="38" subjects_affected="16" subjects_at_risk="31"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single-center design
Small sample size
Homogenous population
Only maintenance dosing phase tested</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Adam E Gaweda</name_or_title>
      <organization>University of Louisville</organization>
      <phone>502-852-0766</phone>
      <email>adam.gaweda@louisville.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
